High Grade Ovarian Serous Adenocarcinoma Clinical Trials

15 clinical trials for High Grade Ovarian Serous Adenocarcinoma across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer — RECRUITING · PHASE1
• Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer — RECRUITING
• Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC — RECRUITING · NA
• Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer — RECRUITING · PHASE2
• Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery — ACTIVE_NOT_RECRUITING · PHASE1
• Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients — ACTIVE_NOT_RECRUITING · PHASE2
• Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — COMPLETED · PHASE1
• mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian — ACTIVE_NOT_RECRUITING · PHASE1
• Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC) — WITHDRAWN · PHASE1
• High Definition Profiling of Ovarian Cancer Ascites — NOT_YET_RECRUITING
• Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer — TERMINATED · NA
• Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers — TERMINATED · PHASE1
• Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — COMPLETED · PHASE1

Refine this search